Clinical Trial Update: Study of Ambrisentan in Participants With Pulmonary Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ambrisentan in participants with pulmonary hypertension; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

Sponsor: Gilead Sciences | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2020-09-30